The report cites two specific case studies — one where WNS enabled a leading US pharma company to improve pneumococcal vaccine uptake through ML-driven patient targeting with 70 percent accuracy, and another where WNS helped a leading EU-based life sciences firm save 30 percent of marketers’ time by developing a cloud-based data and analytics platform and integrating data from 30 countries.

WNS’ investments in Generative AI and Agentic AI, paired with domain depth, are helping life sciences organizations accelerate launch planning, enhance targeting accuracy and streamline post-launch execution. Moreover, WNS’ recent acquisitions, including Kipi.ai, have further strengthened its AI, analytics, automation and commercial intelligence capabilities.

Disclaimer

Licensed extracts taken from Everest Group’s PEAK Matrix® Reports, may be used by licensed third parties for use in their own marketing and promotional activities and collateral. Selected extracts from Everest Group’s PEAK Matrix® reports do not necessarily provide the full context of our research and analysis. All research and analysis conducted by Everest Group’s analysts and included in Everest Group’s PEAK Matrix® reports is independent and no organization has paid a fee to be featured or to influence their ranking. To access the complete research and to learn more about our methodology, please visit Everest Group PEAK Matrix® Reports.

About Everest Group

Everest Group is a leading global research firm helping business leaders make confident decisions. Everest Group's PEAK Matrix® assessments provide the analysis and insights enterprises need to make critical selection decisions about global services providers, locations, and products and solutions within various market segments. Likewise, providers of these services, products, and solutions, look to the PEAK Matrix® to gauge and calibrate their offerings against others in the industry or market. Find further details and in-depth content at http://www.everestgrp.com.